Can I Take Vitamin B6 With Addyi (Flibanserin)?

What Is Flibanserin and How Does It Work?

Flibanserin, sold as Addyi, is the only FDA-approved non-hormonal treatment for acquired, generalized HSDD in premenopausal women. It is taken as a single 100 mg tablet at bedtime. The bedtime requirement is not arbitrary: the FDA-mandated REMS program exists because flibanserin significantly increases the risk of hypotension and syncope when combined with alcohol or CYP3A4 inhibitors, and those risks are worse when a woman is upright.

Mechanism of Action

Flibanserin acts on three receptor systems at once. It is a full agonist at serotonin 5-HT1A receptors, an antagonist at 5-HT2A receptors, and a weak agonist at dopamine D4 receptors. This combination is thought to shift the balance in the prefrontal cortex away from serotonergic inhibition of desire and toward dopaminergic and norepinephrine-driven excitation. The FDA pharmacology review for flibanserin describes this as a "multifunctional serotonin agonist and antagonist" mechanism. [1]

How the Body Processes Flibanserin

Flibanserin is metabolized primarily by CYP3A4 and, to a lesser degree, by CYP2C19 in the liver. [2] Its half-life is approximately 11 hours. Strong CYP3A4 inhibitors, such as fluconazole, itraconazole, or ketoconazole, can raise flibanserin plasma levels by four- to six-fold, which is why they are contraindicated per the FDA label. Moderate CYP3A4 inhibitors require a prescriber conversation before use.

Clinical Efficacy in HSDD Trials

Three Phase 3 trials underpinned FDA approval. Across VIOLET (N=1,060), BEGONIA (N=949), and SNOWDROP (N=542), women on flibanserin reported statistically significant increases in satisfying sexual events and reductions in distress compared to placebo, though the absolute effect sizes were modest: roughly 0.5 to 1.0 additional satisfying sexual events per month over placebo. [3] The FDA advisory committee debated those numbers at length before approval in 2015.

What Is Vitamin B6 and Why Do People Take It?

Vitamin B6 is a water-soluble nutrient that exists in several forms, most notably pyridoxine (the form in most supplements) and pyridoxal-5-phosphate (PLP), the metabolically active coenzyme. The recommended dietary allowance for women aged 19 to 50 is 1.3 mg/day, rising to 1.5 mg/day after 50. [4]

Common Reasons Women Supplement B6

Women take B6 supplements for several reasons: to manage premenstrual syndrome symptoms, to ease morning sickness during pregnancy (often as part of Diclegis/Bonjesta), to support mood via serotonin and dopamine biosynthesis, and to address documented deficiency. Some also take it as part of general B-complex formulas without a specific clinical target.

The Serotonin Synthesis Connection

This is where the question gets clinically interesting. PLP is the coenzyme required by aromatic L-amino acid decarboxylase (AAAD) to convert 5-hydroxytryptophan (5-HTP) into serotonin, and L-DOPA into dopamine. If B6 deficiency reduces AAAD activity, both serotonin and dopamine synthesis can slow. Correcting a deficiency might therefore slightly shift the serotonergic and dopaminergic tone that flibanserin relies on, though no published trial has measured this interaction directly.

Upper Tolerable Intake Level

The NIH Office of Dietary Supplements sets the tolerable upper intake level (UL) for vitamin B6 at 100 mg/day for adults. [4] Sustained intake above 200 mg/day has been associated with sensory peripheral neuropathy, with case reports documenting reversible but sometimes slow-to-resolve numbness, tingling, and ataxia. [5]

Does Vitamin B6 Interact With Flibanserin Pharmacokinetically?

The short answer is: at standard supplement doses, probably not in a clinically meaningful way.

CYP Enzyme Involvement

Flibanserin's two primary metabolic enzymes are CYP3A4 and CYP2C19. [2] Vitamin B6 at typical supplemental doses (10 to 100 mg/day) is not a known inhibitor or inducer of either enzyme based on current pharmacology databases and the NIH's LiverTox resource. [6] There is no published in-vitro or in-vivo study showing that pyridoxine or PLP alters CYP3A4 or CYP2C19 activity at these doses.

P-glycoprotein and Transporter Effects

Flibanserin is also a substrate of P-glycoprotein (P-gp) efflux transporters. No mechanistic data indicate that vitamin B6 affects P-gp activity at supplemental doses. Drug transporter interactions with water-soluble vitamins are generally not a clinical concern unless the vitamin is being given at pharmaceutical doses (grams per day), which is far outside normal supplementation.

What High-Dose B6 Might Theoretically Do

At pharmacological doses (several hundred milligrams per day, far above the UL), pyridoxine could theoretically alter hepatic enzyme activity or affect pyridoxine-dependent enzyme systems involved in neurotransmitter handling. This remains theoretical. No case reports or pharmacovigilance signals in the FDA Adverse Event Reporting System (FAERS) currently document a flibanserin-pyridoxine interaction. Until a dedicated study is conducted, the interaction cannot be fully excluded at very high doses.

HealthRX CYP Risk Stratification for B6 + Flibanserin:

| B6 Daily Dose | CYP3A4 Risk | Practical Category | |---|---|---| | 1.3 to 10 mg (dietary + low-dose supplement) | Negligible | No action needed | | 10 to 100 mg (moderate supplement) | Not established; likely negligible | Disclose to prescriber | | 100 to 200 mg (high supplement) | Unknown; monitor for neuropathy | Use with caution; discuss | | Above 200 mg (therapeutic / off-label) | Unknown; neuropathy risk is real | Avoid without medical supervision |

Does Vitamin B6 Interact With Flibanserin Pharmacodynamically?

This is a more nuanced question than the pharmacokinetic one.

Serotonergic Tone and Flibanserin's Mechanism

Flibanserin's mechanism depends on a specific serotonin receptor balance: suppressing 5-HT2A receptor activity while stimulating 5-HT1A receptors. If vitamin B6 deficiency is meaningfully limiting serotonin synthesis, correcting it could theoretically raise overall serotonergic tone. Whether that helps or slightly blunts flibanserin's net effect on desire is not known. The clinical relevance is probably small given the modest absolute changes B6 supplementation produces in serotonin metabolites.

Dopamine Pathway Overlap

Both flibanserin (via D4 agonism and indirect dopamine facilitation) and vitamin B6 (as a coenzyme for dopamine synthesis) touch the dopaminergic system. Correcting B6 deficiency in a B6-deficient woman could support dopamine synthesis. Whether that produces any measurable additive or conflicting effect on flibanserin response is unknown. No trial data exist.

CNS Depression and Sedation

Flibanserin carries a sedation risk, which is why bedtime dosing is required. Vitamin B6 at standard doses has no established sedative effect. High-dose B6 has not been linked to CNS depression. This particular safety dimension does not appear to be a concern for the B6-flibanserin combination.

What Interactions Should Addyi Users Actually Worry About?

Vitamin B6 is not on the FDA's priority concern list for flibanserin. These are the documented high-risk combinations.

Alcohol

The FDA REMS program highlights alcohol as the single most dangerous co-exposure with flibanserin. Even moderate alcohol consumption significantly increases hypotension and loss-of-consciousness risk. The prescribing information states that women should avoid alcohol entirely while taking Addyi. [7] The mechanism involves additive CNS and cardiovascular depression.

Strong CYP3A4 Inhibitors

Fluconazole (a common antifungal), itraconazole, ketoconazole, clarithromycin, and several HIV antiretrovirals can raise flibanserin exposure four- to six-fold, a dangerous increase. The FDA label lists these as contraindicated. [7]

Moderate CYP3A4 Inhibitors

Grapefruit juice, certain antidepressants, and some hormonal contraceptives can moderately raise flibanserin levels. A prescriber-supervised dose adjustment or monitoring plan is required.

Other CNS Depressants

Benzodiazepines, opioids, sleep aids such as diphenhydramine, and antihistamines can add to flibanserin's sedative burden. Patients should disclose every OTC drug and supplement.

What the Neuropathy Data Actually Show for High-Dose B6

This matters because some B6 supplements sold without a prescription contain 50 to 250 mg per tablet, far above the 1.3 mg RDA.

A 1987 case series published in the New England Journal of Medicine (Schaumburg et al.) documented sensory neuropathy in seven patients taking 2,000 mg/day or more of pyridoxine. [5] Later reports confirmed neuropathy at much lower doses. A 2023 systematic review in the journal Nutrients found case reports of neuropathy at sustained intakes as low as 50 to 100 mg/day in individual patients, though the dose-response relationship below 200 mg/day remains poorly characterized. [8]

The European Food Safety Authority set a safe upper level of 12.5 mg/day for long-term supplemental B6 in adults, considerably more conservative than the U.S. UL of 100 mg/day. [9] This discrepancy reflects genuine scientific uncertainty.

For Addyi users, the neuropathy concern is independent of flibanserin. It applies to any woman taking high-dose B6 long-term. The practical instruction: check your B6 supplement label and stay below 100 mg/day unless a physician has prescribed a higher dose for a specific indication such as B6-responsive anemia or pyridoxine-dependent epilepsy.

Vitamin B6 Forms: Does the Form Matter?

Supplement labels may list pyridoxine hydrochloride (the cheapest and most common form), pyridoxal-5-phosphate (PLP, marketed as "active B6"), or pyridoxamine. For the purposes of the flibanserin interaction question, the form is unlikely to matter since the CYP enzyme question centers on dose rather than form. PLP is already the active coenzyme, so it bypasses the phosphorylation step that converts pyridoxine to PLP in the liver. At equivalent doses, PLP may produce slightly higher peak plasma levels, but neither form has been shown to alter CYP3A4 or CYP2C19 activity.

Monitoring and Practical Clinical Guidance

What to Tell Your Prescriber

Disclose the exact product name, dose per tablet, and how many tablets you take daily. "I take a B-complex" is insufficient. Your prescriber needs milligrams. If you are taking a B-complex, look at the B6 content specifically; some B-complexes contain 50 to 100 mg of B6 per serving despite not emphasizing it on the front label.

Timing of Doses

Flibanserin must be taken at bedtime. Vitamin B6 can be taken at any time of day, typically with food to reduce the mild gastric irritation some people experience. No dose-separation window is required for this combination based on current evidence, because the interaction concern is not about absorption interference.

Symptoms to Watch For

If you take more than 50 mg of supplemental B6 per day alongside Addyi, watch for:

• Numbness or tingling in the hands or feet
• Difficulty with balance or coordination
• Unusual skin sensitivity

These are signs of pyridoxine neuropathy and should prompt a conversation with your prescriber regardless of your Addyi use. They are not specific to flibanserin; they reflect the known B6 toxicity pattern.

Lab Monitoring

Routine plasma pyridoxal-5-phosphate levels are not standard of care for women taking low to moderate B6 supplements, but they may be useful if a patient reports neurological symptoms while taking more than 100 mg/day. Reference range for plasma PLP is typically 20 to 125 nmol/L, though labs vary.

The Bigger Picture: Supplement Disclosure and HSDD Treatment

Women with HSDD often explore multiple avenues simultaneously: hormonal therapies, psychotherapy, pelvic floor physical therapy, supplements, and prescription medications. That makes the supplement disclosure conversation even more important with flibanserin than with many other drugs, because Addyi's narrow therapeutic window and its REMS restrictions mean that unexpected pharmacokinetic changes can push a patient into symptomatic hypotension or excessive sedation.

A 2021 survey published in the Journal of Sexual Medicine found that approximately 74% of women using prescription therapies for sexual dysfunction were also taking at least one dietary supplement without disclosing it to their prescriber. [10] Vitamin complexes were among the most common undisclosed supplements. This is not a trivial omission when the prescription drug involved has contraindicated combinations and a mandatory REMS program.

The FDA prescribing information for flibanserin states directly: "Advise patients to tell their healthcare providers about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements." [7] That instruction applies to vitamin B6.

Summary of the Evidence and Clinical Bottom Line

Vitamin B6 at the doses found in most multivitamins and low-dose B-complex supplements (1 to 10 mg) does not present a recognized pharmacokinetic or pharmacodynamic interaction with flibanserin. At moderate supplemental doses (10 to 100 mg), no established interaction exists, though the evidence base is limited because no dedicated interaction study has been conducted. Above 100 mg/day, the primary risk shifts away from flibanserin pharmacology and toward the independent toxicity of high-dose B6, specifically peripheral sensory neuropathy.

Women taking Addyi who want to supplement with B6 should keep their total daily B6 intake below 100 mg, disclose the supplement to their prescriber at every visit, and stay alert to neurological symptoms if using higher doses. The far more pressing interactions to avoid with Addyi remain alcohol and strong CYP3A4 inhibitors.

Per the FDA-approved prescribing information for Addyi, women should take flibanserin 100 mg at bedtime and must not consume alcohol on the same day. [7]